HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes.

Abstract
Lanthionine synthetase component C-like protein 2 (LANCL2) is a member of the LANCL protein family, which is broadly expressed throughout the body. LANCL2 is the molecular target of abscisic acid (ABA), a compound with insulin-sensitizing and immune modulatory actions. LANCL2 is required for membrane binding and signaling of ABA in immune cells. Direct binding of ABA to LANCL2 was predicted in silico using molecular modeling approaches and validated experimentally using ligand-binding assays and kinetic surface plasmon resonance studies. The therapeutic potential of the LANCL2 pathway ranges from increasing cellular sensitivity to anticancer drugs, insulin-sensitizing effects and modulating immune and inflammatory responses in the context of immune-mediated and infectious diseases. A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice. This review discusses the value of LANCL2 as a novel therapeutic target for the discovery and development of new classes of orally active drugs against chronic metabolic, immune-mediated and infectious diseases.
AuthorsPinyi Lu, Raquel Hontecillas, Casandra W Philipson, Josep Bassaganya-Riera
JournalCurrent drug targets (Curr Drug Targets) Vol. 15 Issue 6 Pg. 565-72 (Jun 2014) ISSN: 1873-5592 [Electronic] United Arab Emirates
PMID24628287 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Anti-Inflammatory Agents
  • Hypoglycemic Agents
  • LANCL2 protein, human
  • Membrane Proteins
  • Nuclear Proteins
  • Phosphate-Binding Proteins
  • Abscisic Acid
Topics
  • Abscisic Acid (metabolism)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Humans
  • Hypoglycemic Agents (pharmacology)
  • Inflammation (drug therapy, metabolism)
  • Membrane Proteins (antagonists & inhibitors, chemistry, genetics, metabolism)
  • Mice
  • Models, Molecular
  • Nuclear Proteins (antagonists & inhibitors)
  • Phosphate-Binding Proteins
  • Protein Conformation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: